SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-081577
Filing Date
2024-03-29
Accepted
2024-03-29 08:21:50
Documents
19
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A d706699dpre14a.htm   iXBRL PRE 14A 1435161
6 GRAPHIC g706699dsp145.jpg GRAPHIC 153917
7 GRAPHIC g706699dsp146.jpg GRAPHIC 180216
8 GRAPHIC g706699g52q25.jpg GRAPHIC 139712
9 GRAPHIC g706699g85y72.jpg GRAPHIC 120404
  Complete submission text file 0001193125-24-081577.txt   3818147

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrus-20231231.xsd EX-101.SCH 6466
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrus-20231231_def.xml EX-101.DEF 3959
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20231231_lab.xml EX-101.LAB 10626
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20231231_pre.xml EX-101.PRE 7003
22 EXTRACTED XBRL INSTANCE DOCUMENT d706699dpre14a_htm.xml XML 234524
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37773 | Film No.: 24802089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)